Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Arrowhead Pharmaceuticals, Inc. (ARWR) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$3.55M |
|
$-132.86M |
|
-- |
|
$3.55M |
|
$140.10M |
|
$-136.54M |
|
$-2.14M |
|
$-138.69M |
|
$-138.69M |
|
$-135.38M |
|
$-135.38M |
|
$-135.38M |
|
$-135.38M |
|
$-136.54M |
|
$-133.12M |
|
107.42M |
|
107.42M |
|
$-1.24 |
|
$-1.24 |
|
| Balance Sheet Financials | |
$237.90M |
|
$333.41M |
|
$388.39M |
|
$626.29M |
|
$63.72M |
|
-- |
|
$388.85M |
|
$452.57M |
|
$173.71M |
|
$163.88M |
|
$173.71M |
|
107.50M |
|
| Cash Flow Statement Financials | |
$-117.84M |
|
$64.84M |
|
$0.27M |
|
$110.89M |
|
$58.22M |
|
$-52.68M |
|
$19.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.73 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-3845.25% |
|
-3845.25% |
|
-- |
|
-3905.63% |
|
-3741.59% |
|
$-186.50M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-77.93% |
|
-82.61% |
|
-21.62% |
|
-77.93% |
|
$1.62 |
|
$-1.74 |
|
$-1.10 |
|